A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 17, Pages 10014
Publisher
MDPI AG
Online
2022-09-06
DOI
10.3390/ijms231710014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1
- (2022) Tingwei Zhao et al. Oxidative Medicine and Cellular Longevity
- HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
- (2022) Garyfallia Pantelaiou-Prokaki et al. Clinical Epigenetics
- Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
- (2022) Alessandro Papa et al. Cells
- Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
- (2022) Martina Korfei et al. Cells
- Long noncoding RNA LINC01435 impedes diabetic wound healing by facilitating YY1-mediated HDAC8 expression
- (2022) Wan Fu et al. iScience
- Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability
- (2022) Stefano Federico et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
- (2022) Salma Darwish et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Notch signaling: A possible therapeutic target and its role in diabetic foot ulcers
- (2022) Farmiza Begum et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8
- (2022) Zhiqiang Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
- (2022) Camille Hauguel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Strategies to Design Selective Histone Deacetylase Inhibitors
- (2021) Wolfgang Sippl et al. ChemMedChem
- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway
- (2021) Sarah Mazzotta et al. BIOORGANIC CHEMISTRY
- Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
- (2021) Olasunkanmi O. Olaoye et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
- (2021) Xin-Hui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Duchenne muscular dystrophy
- (2021) Dongsheng Duan et al. Nature Reviews Disease Primers
- Recent developments of HDAC inhibitors: Emerging indications and novel molecules
- (2021) Andrey D. Bondarev et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
- (2021) Weiqin Yang et al. Science Translational Medicine
- Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
- (2021) Tingwei Zhao et al. Frontiers in Pharmacology
- Histone‐deacetylase 8 drives the immune response and the growth of glioma
- (2021) Alessandro Mormino et al. GLIA
- Inhibiting HDAC3 (Histone Deacetylase 3) Aberration and the Resultant Nrf2 (Nuclear Factor Erythroid-Derived 2-Related Factor-2) Repression Mitigates Pulmonary Fibrosis
- (2021) Fang Chen et al. HYPERTENSION
- Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
- (2021) Giuseppe Campiani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy
- (2021) Marco Spreafico et al. PHARMACOLOGICAL RESEARCH
- The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene
- (2021) Simonetta Andrea Licandro et al. Skeletal Muscle
- Gene Therapy for Duchenne Muscular Dystrophy
- (2021) Nertiyan Elangkovan et al. Journal of Neuromuscular Diseases
- Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
- (2021) Hao Yan et al. BIOMEDICINE & PHARMACOTHERAPY
- Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
- (2021) Xingrui He et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC Inhibition to Prime Immune Checkpoint Inhibitors
- (2021) Edith Borcoman et al. Cancers
- Exploring the binding mechanism of HDAC8 selective inhibitors: Lessons from the modification of Cap group
- (2020) Min Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1
- (2020) Ehab Ghazy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis
- (2020) Yunhe Zhang et al. FASEB JOURNAL
- Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
- (2020) Brianna Burke et al. Frontiers in Oncology
- Retinitis Pigmentosa and Retinal Degenerations: Deciphering Pathways and Targets for Drug Discovery and Development
- (2020) Gabriele Carullo et al. ACS Chemical Neuroscience
- An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators
- (2020) Jintong Du et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation
- (2020) Neha Upadhyay et al. BIOORGANIC CHEMISTRY
- HDAC8 Inhibition Reduces Lesional Iba-1+ Cell Infiltration after Spinal Cord Injury without Effects on Functional Recovery
- (2020) Sven Hendrix et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting
- (2020) Muhammad Murtaza Hassan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Baicalein: A metabolite with promising antineoplastic activity
- (2020) Hardeep Singh Tuli et al. LIFE SCIENCES
- HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals
- (2020) Panpan An et al. ONCOGENE
- Mantonico and Pecorello Grape Seed Extracts: Chemical Characterization and Evaluation of In Vitro Wound-Healing and Anti-Inflammatory Activities
- (2020) Gabriele Carullo et al. Pharmaceuticals
- Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
- (2020) Joshua P. Smalley et al. MOLECULES
- Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
- (2020) A. Prasanth Saraswati et al. ACS Medicinal Chemistry Letters
- HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
- (2020) Marco Spreafico et al. Frontiers in Cell and Developmental Biology
- Natural HDAC‐1/8 inhibitor baicalein exerts therapeutic effect in CBF‐AML
- (2020) Xiaoxuan Yu et al. Clinical and Translational Medicine
- Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function
- (2020) January M. Watters et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis
- (2020) Chang Hun Lee et al. BIOCHEMICAL PHARMACOLOGY
- Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues
- (2020) Hua Miao et al. PHARMACOLOGICAL RESEARCH
- HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
- (2020) Kamira Maharaj et al. Frontiers in Immunology
- Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
- (2020) Nicola Relitti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HADC8 Inhibitor WK2-16 Therapeutically Targets Lipopolysaccharide-Induced Mouse Model of Neuroinflammation and Microglial Activation
- (2019) Fan-Li Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Translational research in pulmonary fibrosis
- (2019) Susan K. Mathai et al. Translational Research
- HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
- (2019) Somy Yoon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation
- (2019) Abdullahi Ibrahim Uba et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
- (2019) Ya‐Long Feng et al. MEDICINAL RESEARCH REVIEWS
- Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- (2019) Tessa Knox et al. Scientific Reports
- Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
- (2019) Mar Cuadrado-Tejedor et al. Frontiers in Aging Neuroscience
- Dual Roles of the AMP-Activated Protein Kinase Pathway in Angiogenesis
- (2019) Li et al. Cells
- Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
- (2019) Margherita Brindisi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quercetin‐3‐Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40
- (2019) Gabriele Carullo et al. ChemistrySelect
- Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity
- (2019) Prakruti Trivedi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach
- (2019) Patrizia Sarogni et al. JOURNAL OF MEDICAL GENETICS
- Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation
- (2019) Sudhan Debnath et al. Scientific Reports
- Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
- (2019) Fulvio Saccoccia et al. ACS Infectious Diseases
- Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines
- (2019) Kalpana Tilekar et al. BIOORGANIC CHEMISTRY
- Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
- (2019) Nicholas J Porter et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors
- (2019) Benjamin Wolff et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Induction of Apoptosis and Autophagy in Breast Cancer Cells by a Novel HDAC8 Inhibitor
- (2019) Chang-Fang Chiu et al. Biomolecules
- The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
- (2018) Fiona R. Kolbinger et al. ARCHIVES OF TOXICOLOGY
- HDAC8 regulates neural differentiation through embryoid body formation in P19 cells
- (2018) Syouichi Katayama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
- (2018) G. R. Vanaja et al. Cell Communication and Signaling
- A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
- (2018) Jing Shen et al. CELL DEATH AND DIFFERENTIATION
- A Functional Mutation in HDAC8 Gene as Novel Diagnostic Marker for Cornelia De Lange Syndrome
- (2018) Xueren Gao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling
- (2018) Yun Zhang et al. CLINICAL SCIENCE
- Discovery of meta -sulfamoyl N -hydroxybenzamides as HDAC8 selective inhibitors
- (2018) Chunlong Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity
- (2018) Ahmed T. Negmeldin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on isocombretastatin A-4
- (2018) Diana Lamaa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Renal fibrosis: Recent translational aspects
- (2018) Hélène François et al. MATRIX BIOLOGY
- Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement
- (2018) Antonie D. Kline et al. NATURE REVIEWS GENETICS
- HDAC Inhibitors: Novel Immunosuppressants for Allo- and Xeno- Transplantation
- (2018) Qing Zhang et al. ChemistrySelect
- Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
- (2018) Margherita Brindisi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors
- (2018) Rekha Sangwan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC8 inhibition ameliorates pulmonary fibrosis
- (2018) Shigeki Saito et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
- (2018) Martin Marek et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
- (2018) Suvankar Banerjee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders
- (2017) Biswanath Dinda et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
- (2017) Yue Zhong et al. Expert Opinion on Drug Discovery
- TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
- (2017) Evangelia Pardali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides
- (2017) Carol Ann Castañeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
- (2017) Tino Heimburg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
- (2017) Ryan Lillico et al. JOURNAL OF PROTEOME RESEARCH
- Cinnamaldehyde, cinnamic acid, and cinnamyl alcohol, the bioactives of Cinnamomum cassia exhibit HDAC8 inhibitory activity: An In vitro and In silico study
- (2017) Ruchika Kaul-Ghanekar et al. Pharmacognosy Magazine
- Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
- (2017) Sk. Abdul Amin et al. PHARMACOLOGICAL RESEARCH
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors
- (2017) Taha Y. Taha et al. ACS Medicinal Chemistry Letters
- Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity
- (2017) Ahmed T. Negmeldin et al. ACS Medicinal Chemistry Letters
- HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine
- (2016) Pornpun Aramsangtienchai et al. ACS Chemical Biology
- Structural and Functional Influence of the Glycine-Rich Loop G302GGGY on the Catalytic Tyrosine of Histone Deacetylase 8
- (2016) Nicholas J. Porter et al. BIOCHEMISTRY
- Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity
- (2016) Vijaya Rao Pidugu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors
- (2016) Alexander Kleinschek et al. ChemMedChem
- HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
- (2016) Hong Zheng et al. CLINICAL CANCER RESEARCH
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases
- (2016) Alokta Chakrabarti et al. Future Medicinal Chemistry
- Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
- (2016) Tushar D. Bhagat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells
- (2016) Tanushree Dasgupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
- (2016) Daniel A. Rodrigues et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of ‘linkerless’ hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket
- (2016) Alexa A. Tabackman et al. JOURNAL OF STRUCTURAL BIOLOGY
- Development of a Potent and Selective HDAC8 Inhibitor
- (2016) Oscar J. Ingham et al. ACS Medicinal Chemistry Letters
- HDAC inhibitors with PD-1 blockade: a promising strategy for treatment of multiple cancer types?
- (2016) Amer A Beg et al. Epigenomics
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
- (2016) Elizabeth E. Hull et al. Biomed Research International
- Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors
- (2015) Jelena Melesina et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- HDAC8: a multifaceted target for therapeutic interventions
- (2015) Alokta Chakrabarti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation
- (2015) I Rettig et al. Cell Death & Disease
- Compromised Structure and Function of HDAC8 Mutants Identified in Cornelia de Lange Syndrome Spectrum Disorders
- (2014) Christophe Decroos et al. ACS Chemical Biology
- A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
- (2014) Ki Cheong Park et al. BRITISH JOURNAL OF PHARMACOLOGY
- Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8-Selective Inhibitors
- (2014) Takayoshi Suzuki et al. ChemMedChem
- Current Treatment and Management of Dystrophinopathies
- (2014) Nathalie Goemans et al. Current Treatment Options in Neurology
- Clinical utility gene card for: Cornelia de Lange syndrome
- (2014) Feliciano J Ramos et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation
- (2014) JS Aher et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance
- (2014) Frank J. Kaiser et al. HUMAN MOLECULAR GENETICS
- Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
- (2014) Guozhi Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania
- (2014) Laura Stertz et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Fibroblasts in fibrosis: novel roles and mediators
- (2014) Ryan T. Kendall et al. Frontiers in Pharmacology
- Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif
- (2013) Florence F. Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
- (2013) David E. Olson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unknown
- (2013) Silvia Consalvi et al. MOLECULAR MEDICINE
- Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors
- (2013) Indrek Koppel et al. NEUROPHARMACOLOGY
- The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C6 position
- (2012) Sun Ea Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HDAC8 substrates: Histones and beyond
- (2012) Noah A. Wolfson et al. BIOPOLYMERS
- Plant HDAC inhibitor chrysin arrest cell growth and induce p21 WAF1 by altering chromatin of STAT response element in A375 cells
- (2012) Manika Pal-Bhadra et al. BMC CANCER
- Synthesis and Biological Evaluation ofortho-ArylN-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors
- (2012) Wei-Jan Huang et al. ChemMedChem
- Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
- (2012) Praveer Gupta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
- (2012) Nambirajan Govindarajan et al. EMBO Molecular Medicine
- Chrysin: A Histone Deacetylase 8 Inhibitor with Anticancer Activity and a Suitable Candidate for the Standardization of Chinese Propolis
- (2012) Li-Ping Sun et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
- (2012) Takayoshi Suzuki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inflammasomes in wound healing and fibrosis
- (2012) Carol M Artlett JOURNAL OF PATHOLOGY
- HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
- (2012) Matthew A. Deardorff et al. NATURE
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- NMR Profiling of Histone Deacetylase and Acetyl-transferase Activities in Real Time
- (2011) Alexander Dose et al. ACS Chemical Biology
- Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate
- (2011) Raushan K. Singh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity
- (2011) Sun Ea Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of histone deacetylase 8 selective inhibitors
- (2011) Weiping Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
- (2011) Magdalena Karolczak-Bayatti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of Tetrahydroisoquinoline-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities
- (2011) Yingjie Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, Docking, and Biological Evaluation of Novel Diazide-Containing Isoxazole- and Pyrazole-Based Histone Deacetylase Probes
- (2011) Raghupathi Neelarapu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer
- (2011) Chang Park ONCOLOGY REPORTS
- Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
- (2010) M. Pang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
- (2010) Brian J. Wilson et al. MOLECULAR ENDOCRINOLOGY
- Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
- (2009) Weichao Guo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Combining Mass Spectrometry and Peptide Arrays to Profile the Specificities of Histone Deacetylases
- (2009) Zachary A. Gurard-Levin et al. CHEMBIOCHEM
- Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors
- (2009) Paola Galletti et al. ChemMedChem
- Targeting of HDAC8 and investigational inhibitors in neuroblastoma
- (2009) Ina Oehme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells
- (2009) Yong Wang et al. NEUROSCIENCE LETTERS
- Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors†,‡
- (2008) Daniel P. Dowling et al. BIOCHEMISTRY
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin
- (2008) Fang Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search